King Luther Capital Management Corp Horizon Therapeutics Public LTD CO Transaction History

King Luther Capital Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $2.39 Million - $3.43 Million	-40,492 Reduced 71.13%	16,434 $1.02 Million
Q2 2022 Aug 11, 2022	BUY	$79.4 - $116.36 $3.35 Million - $4.91 Million	42,201 Added 286.59%	56,926 $4.54 Million
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $405,741 - $515,557	4,695 Added 46.81%	14,725 $1.55 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $36,467 - $44,366	370 Added 3.83%	10,030 $1.08 Million
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $53,767 - $64,566	-585 Reduced 5.71%	9,660 $1.06 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $19,404 - $21,582	-225 Reduced 2.15%	10,245 $959,000
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $164,485 - $207,177	-2,455 Reduced 18.99%	10,470 $766,000
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $131,171 - $189,833	-2,375 Reduced 15.52%	12,925 $1 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $3.39 Million - $6.39 Million	-112,140 Reduced 87.99%	15,300 $850,000
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $3.17 Million - $4.91 Million	127,440 New	127,440 $3.78 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.